2nd Umicore Catalysis Symposium

Uniting Innovators in San Francisco

Leading Industry Experts Converge for Insights and Collaboration

Umicore PMC hosted its second Umicore Catalysis Symposium in San Francisco, CA, drawing about 50 scientists from leading Bay Area pharmaceutical companies like Genentech and Gilead, among others. The event featured a lineup of technical presentations by esteemed experts.

Prof. Neufeldt, Montana State University
Promising advancements in achieving cross-coupling at less reactive C-X bonds in heteroarenes.

James Murray, Amgen
Sotorasib® development utilizing Reaction Progress Kinetic Analysis.

Kyle Mack, Genentech
Optimization of enantioselective cross-coupling via machine learning.

Haifeng Yang, Merck & Co, Inc.
New catalytic methods for late-stage tritiation of sp3 C-H bonds.

Achim Link, Solvias
Efficient asymmetric hydrogenation at an industrial scale through catalyst screening and optimization.

Joshua Dunetz, Gilead
Sonogashira carbonylation in synthesizing their early-phase development drug candidate.

Prof. Rovis, Columbia University
The development of Os-based catalysts enabling low-energy excitation photoredox catalysis.

Philip Wheeler, Umicore
The importance of metal catalysis in sustainable chemical processes and the value of planning metal separation and recycling steps in process development.